JMJD1B Demethylates H4R3me2s and H3K9me2 to Facilitate Gene Expression for Development of Hematopoietic Stem and Progenitor Cells
2018 · Cell Reports · 101 citations
https://doi.org/10.1016/j.celrep.2018.03.051
L
Ling Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
129
Papers
5.2K
Citations
33
h-index
55
i10-index
Ling Li is an academic researcher from Huaqiao University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Epigenetics and DNA Methylation & Histone Deacetylase Inhibitors Research. The author has an h-index of 33, co-authored 110 publications.
ORCID: 0000-0001-7568-939XPapers by this author
worksDistinct prognostic values of S100 mRNA expression in breast cancer
2017 · Scientific Reports · 90 citations
https://doi.org/10.1038/srep39786
Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents
2021 · Journal of Medicinal Chemistry · 54 citations
https://doi.org/10.1021/acs.jmedchem.1c00413
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis
2023 · Nature Communications · 26 citations
https://doi.org/10.1038/s41467-023-41167-z
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity
2024 · Nature Cancer · 26 citations
https://doi.org/10.1038/s43018-024-00736-x
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma
2025 · JAMA · 19 citations
https://doi.org/10.1001/jama.2025.13205
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat